FDA Approves Abbott HPV Test for Molecular PCR Platform
Abbott received FDA approval for its molecular HPV screening solution for its Alinity m family of diagnostic assays.
Read MorePosted by Andy Lundin | Nov 2, 2023 | Cervical (HPV), Molecular Diagnostics |
Abbott received FDA approval for its molecular HPV screening solution for its Alinity m family of diagnostic assays.
Read MorePosted by Andy Lundin | Nov 2, 2023 | Information Technology |
Genomenon says it is delivering a catalog of more than 9,000 gene-disease relationships across 5,500 genes, with more being added each week.
Read MorePosted by Andy Lundin | Nov 1, 2023 | Cancer |
Researchers developed a highly sensitive blood test that detects a key protein produced by cancer cells, showing promise for early detection.
Read MorePosted by Andy Lundin | Oct 30, 2023 | Company News, Dementias & Alzheimer’s |
Diadem formed a strategic collaboration with Quest Diagnostics to improve access to blood tests for evaluating the risk of Alzheimer’s.
Read MorePosted by Andy Lundin | Oct 26, 2023 | Cancer, Company News |
QIAGEN and Myriad Genetics announced a new master collaboration agreement to develop companion diagnostic tests in the field of cancer.
Read More